About
Belay Diagnostics is a biotech startup focused on redefining the detection of brain and spinal cord cancers through advanced cerebrospinal fluid (CSF) testing platforms. The company is based in Chicago and has recently signed a lease for laboratory space at Fulton Labs.
Focus
Office
Lease
Markets
Headquarters
Chicago, Illinois, United States
FAQs
Belay Diagnostics has financed 1 deal.
Belay Diagnostics's most recent deal was on August 07, 2023.
Member since: October 2024